Owner The Regents of the University of California Cortex Pharmaceuticals, Inc. Wake Forest University Health Sciences

Inventors Porrino, Linda J.; Lynch, Gary S.; Hampson, Robert E.; Rogers, Gary A.; Deadwyler, Sam A.

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-B-2004204814

PCT Pub. Number WO2004/062616

Priority 60/439,735 13.01.03 US

Filing date 13 January 2004

Wipo publication date 29 July 2004

Acceptance publication date 8 October 2009

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/00 (2006.01)

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/454 (2006.01)

A61K 31/497 (2006.01)

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/5365 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5377 (2006.01)

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61M 1/00 (2006.01) Suction or pumping devices for medical purposes

A61P 25/20 (2006.01) Drugs for disorders of the nervous system